Compared with controls , CBI participants had significantly lower rates of any cannabis use over 12 months ( 24.16 % , 16.82 % , respectively , P < 0.05 ) , frequency of cannabis use at 3 and 6 months ( P < 0.05 ) and other drug use at 3 months ( P < 0.01 ) .